ContractPulse
Open TenderValue not disclosed

Biological Sample Processing, Genotyping, and Storage

Our Future Health (Akeso&Co acting on behalf of)
services

Contract Details

Tender Value
£212,000,000
Stage
Open Tender
Published

Timeline

Disclosed
Start
End

Description

Text to be corrected in the original notice: Place of text to be modified: II.2.3 Instead of: UKH EAST OF ENGLAND UKI LONDON UKF EAST MIDLANDS (ENGLAND) UKG WEST MIDLANDS (ENGLAND) UKL WALES UKM SCOTLAND UKJ SOUTH EAST (ENGLAND) UKK SOUTH WEST (ENGLAND) UKE YORKSHIRE AND THE HUMBER UKD NORTH WEST (ENGLAND) UKC NORTH EAST (ENGLAND) Read: UKH EAST OF ENGLAND UKI LONDON UKF EAST MIDLANDS (ENGLAND) UKG WEST MIDLANDS (ENGLAND) UKL WALES UKM SCOTLAND UKJ SOUTH EAST (ENGLAND) UKK SOUTH WEST (ENGLAND) UKE YORKSHIRE AND THE HUMBER UKD NORTH WEST (ENGLAND) UKC NORTH EAST (ENGLAND) UKN NORTHERN IRELAND Place of text to be modified: II.2.3 Instead of: UKH EAST OF ENGLAND UKI LONDON UKF EAST MIDLANDS (ENGLAND) UKG WEST MIDLANDS (ENGLAND) UKL WALES UKM SCOTLAND UKJ SOUTH EAST (ENGLAND) UKK SOUTH WEST (ENGLAND) UKE YORKSHIRE AND THE HUMBER UKD NORTH WEST (ENGLAND) UKC NORTH EAST (ENGLAND) Read: UKH EAST OF ENGLAND UKI LONDON UKF EAST MIDLANDS (ENGLAND) UKG WEST MIDLANDS (ENGLAND) UKL WALES UKM SCOTLAND UKJ SOUTH EAST (ENGLAND) UKK SOUTH WEST (ENGLAND) UKE YORKSHIRE AND THE HUMBER UKD NORTH WEST (ENGLAND) UKC NORTH EAST (ENGLAND) UKN NORTHERN IRELAND Place of text to be modified: I.1 Instead of: M3 5JL Read: M3 5GS Other additional information: The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement. The scope of the procurement is receipt, processing and DNA extraction of blood samples from 5 million participants; design, manufacture and assessment of a high-throughput genome-wide genotype assay; the provision of a genotype service; and ultra-low temperature, long term storage of plasma, buffy coat, and DNA. The aim for commencement of these agreements is December 2021.

Related Contracts

Ref: 3e6da042-f359-4d54-adca-9f2a6ef4793b-462573 · Sourced from Contracts Finder

View source notice